Denali Therapeutics Inc.
DNLI
$19.80
$0.341.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 987.68M | 867.88M | 848.20M | 898.95M | 817.93M |
| Total Receivables | 1.60M | 2.18M | 1.90M | 1.40M | 1.70M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 33.47M | 30.60M | 32.49M | 34.35M | 59.01M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.02B | 900.66M | 882.60M | 934.71M | 878.64M |
|
|
|||||
| Total Current Assets | 1.02B | 900.66M | 882.60M | 934.71M | 878.64M |
| Net Property, Plant & Equipment | 117.27M | 119.94M | 123.21M | 130.10M | 129.93M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 36.00M | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.22M | 10.94M | 10.11M | 22.97M | 26.93M |
| Total Assets | 1.27B | 1.14B | 1.06B | 1.17B | 1.27B |
|
|
|||||
| Total Accounts Payable | 40.38M | 3.33M | 6.75M | 10.84M | 8.46M |
| Total Accrued Expenses | 44.80M | 64.37M | 51.58M | 50.07M | 54.56M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.86M | 9.55M | 9.24M | 10.29M | 11.52M |
| Total Finance Division Other Current Liabilities | 15.12M | 21.10M | 22.58M | 19.86M | 17.34M |
| Total Other Current Liabilities | 15.12M | 21.10M | 22.58M | 19.86M | 17.34M |
| Total Current Liabilities | 110.16M | 98.35M | 90.15M | 91.06M | 91.88M |
|
|
|||||
| Total Current Liabilities | 110.16M | 98.35M | 90.15M | 91.06M | 91.88M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 30.19M | 32.74M | 35.24M | 37.69M | 40.05M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 199.58M | -- | 4.04M | 10.44M | 16.73M |
| Total Liabilities | 339.93M | 131.09M | 129.42M | 139.19M | 148.66M |
|
|
|||||
| Common Stock & APIC | 3.11B | 3.06B | 2.85B | 2.82B | 2.79B |
| Retained Earnings | -2.18B | -2.05B | -1.92B | -1.80B | -1.67B |
| Treasury Stock & Other | -682.00K | 682.00K | 1.10M | 939.00K | 2.04M |
| Total Common Equity | 926.10M | 1.01B | 926.20M | 1.03B | 1.12B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 926.10M | 1.01B | 926.20M | 1.03B | 1.12B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 926.10M | 1.01B | 926.20M | 1.03B | 1.12B |
|
|
|||||